Phase 2 and 3 clinical trials for the Moderna vaccine (shot) included people from the following racial and ethnic categories: ·

• 79.4% White ·
• 20.0% Hispanic/Latino ·
• 9.7% African American ·
• 4.7% Asian ·
• Less than 3% other races/ethnicities

Age and sex breakdown: ·

• 52.6% male ·
• 47.4% female ·
• 25.3% 65 years and older

The most frequent underlying medical conditions were severe obesity (6.5%), and significant cardiac disease (4.9%).

More information about who was in the trial is listed at https://www.fda.gov/media/144434/download.